10x Genomics, Inc. (FRA:1KJ)

10x Genomics Statistics

Total Valuation

10x Genomics has a market cap or net worth of EUR 1.97 billion. The enterprise value is 1.63 billion.

Market Cap	1.97B
Enterprise Value	1.63B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	116.47M
Shares Outstanding	n/a
Shares Change (YoY)	+3.07%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	8.10%
Owned by Institutions (%)	94.52%
Float	114.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.60
PB Ratio	2.94
P/TBV Ratio	3.23
P/FCF Ratio	28.28
P/OCF Ratio	26.09
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-25.03
EV / Sales	2.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	23.40

Financial Position

The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.11.

Current Ratio	4.48
Quick Ratio	3.93
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	1.07
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.12% and return on invested capital (ROIC) is -9.85%.

Return on Equity (ROE)	-10.12%
Return on Assets (ROA)	-8.42%
Return on Invested Capital (ROIC)	-9.85%
Return on Capital Employed (ROCE)	-15.04%
Revenue Per Employee	418,850
Profits Per Employee	-49,807
Employee Count	1,306
Asset Turnover	0.65
Inventory Turnover	2.56

Taxes

In the past 12 months, 10x Genomics has paid 2.75 million in taxes.

Income Tax	2.75M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+15.26%
50-Day Moving Average	11.98
200-Day Moving Average	10.16
Relative Strength Index (RSI)	67.64
Average Volume (20 Days)	159

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.40

Income Statement

In the last 12 months, 10x Genomics had revenue of EUR 547.02 million and -65.05 million in losses. Loss per share was -0.53.

Revenue	547.02M
Gross Profit	377.14M
Operating Income	-112.83M
Pretax Income	-62.30M
Net Income	-65.05M
EBITDA	-83.10M
EBIT	-112.83M
Loss Per Share	-0.53

Balance Sheet

The company has 410.88 million in cash and 74.14 million in debt, giving a net cash position of 336.74 million.

Cash & Cash Equivalents	410.88M
Total Debt	74.14M
Net Cash	336.74M
Net Cash Per Share	n/a
Equity (Book Value)	669.16M
Book Value Per Share	5.29
Working Capital	436.81M

Cash Flow

In the last 12 months, operating cash flow was 75.45 million and capital expenditures -5.86 million, giving a free cash flow of 69.59 million.

Operating Cash Flow	75.45M
Capital Expenditures	-5.86M
Free Cash Flow	69.59M
FCF Per Share	n/a

Margins

Gross margin is 68.94%, with operating and profit margins of -20.63% and -11.89%.

Gross Margin	68.94%
Operating Margin	-20.63%
Pretax Margin	-11.39%
Profit Margin	-11.89%
EBITDA Margin	-15.19%
EBIT Margin	-20.63%
FCF Margin	12.72%

Dividends & Yields

10x Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.07%
Shareholder Yield	-3.07%
Earnings Yield	-3.30%
FCF Yield	3.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

10x Genomics has an Altman Z-Score of 2.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.6
Piotroski F-Score	3